TY  - GEN
AU  - Guo,Shan-Shan
AU  - Tang,Lin-Quan
AU  - Chen,Qiu-Yan
AU  - Zhang,Lu
AU  - Liu,Li-Ting
AU  - Guo,Ling
AU  - Mo,Hao-Yuan
AU  - Luo,Dong-Hua
AU  - Huang,Pei-Yu
AU  - Xiang,Yan-Qun
AU  - Sun,Rui
AU  - Chen,Ming-Yuan
AU  - Wang,Lin
AU  - Lv,Xing
AU  - Zhao,Chong
AU  - Guo,Xiang
AU  - Cao,Ka-Jia
AU  - Qian,Chao-Nan
AU  - Zeng,Mu-Shen
AU  - Bei,Jin-Xin
AU  - Hong,Ming-Huang
AU  - Shao,Jian-Yong
AU  - Sun,Ying
AU  - Ma,Jun
AU  - Mai,Hai-Qiang
TI  - Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched study
SN  - 1949-2553
PY  - 2018///0112
KW  - Adult
KW  - Aged
KW  - Carcinoma
KW  - mortality
KW  - Chemoradiotherapy
KW  - methods
KW  - DNA, Viral
KW  - Disease-Free Survival
KW  - Epstein-Barr Virus Infections
KW  - complications
KW  - Female
KW  - Herpesvirus 4, Human
KW  - Humans
KW  - Induction Chemotherapy
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Nasopharyngeal Carcinoma
KW  - Nasopharyngeal Neoplasms
KW  - Retrospective Studies
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.18632/oncotarget.8828
ER  -